TW200502236A - Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents - Google Patents

Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents

Info

Publication number
TW200502236A
TW200502236A TW093107825A TW93107825A TW200502236A TW 200502236 A TW200502236 A TW 200502236A TW 093107825 A TW093107825 A TW 093107825A TW 93107825 A TW93107825 A TW 93107825A TW 200502236 A TW200502236 A TW 200502236A
Authority
TW
Taiwan
Prior art keywords
manufacture
pyrimidin
carboxylic acid
acid derivatives
pharmaceutical agents
Prior art date
Application number
TW093107825A
Other languages
English (en)
Inventor
Konrad Honold
Wolfgang Schaefer
Stefan Scheiblich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TW200502236A publication Critical patent/TW200502236A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW093107825A 2003-03-28 2004-03-23 Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents TW200502236A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03007182 2003-03-28

Publications (1)

Publication Number Publication Date
TW200502236A true TW200502236A (en) 2005-01-16

Family

ID=33040927

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093107825A TW200502236A (en) 2003-03-28 2004-03-23 Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents

Country Status (11)

Country Link
US (1) US7163941B2 (zh)
EP (1) EP1615921B1 (zh)
JP (1) JP2006515018A (zh)
CN (1) CN100341873C (zh)
AR (1) AR043921A1 (zh)
AT (1) ATE425976T1 (zh)
CA (1) CA2515605A1 (zh)
CL (1) CL2004000631A1 (zh)
DE (1) DE602004020063D1 (zh)
TW (1) TW200502236A (zh)
WO (1) WO2004085436A2 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) * 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
DE102004054215A1 (de) 2004-11-10 2006-05-11 Merck Patent Gmbh Pyridopyrimidinonderivate
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
FR2933700B1 (fr) * 2008-07-08 2010-07-30 Sanofi Aventis Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
SG10201805807PA (en) 2012-06-26 2018-08-30 Del Mar Pharmaceuticals Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
CN1085666C (zh) 1994-11-14 2002-05-29 沃尼尔·朗伯公司 用于抑制蛋白质酪氨酸激酶介导的细胞增殖的6-芳基吡啶并[2,3-d]嘧啶和1,5-二氮杂萘
WO2001055147A1 (en) 2000-01-25 2001-08-02 Warner-Lambert Company PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
US6803840B2 (en) 2001-03-30 2004-10-12 California Institute Of Technology Pattern-aligned carbon nanotube growth and tunable resonator apparatus
WO2002090360A1 (en) 2001-05-10 2002-11-14 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
WO2003000011A2 (en) 2001-06-21 2003-01-03 Ariad Pharmaceuticals, Inc. Novel pyridopyrimidines and uses thereof

Also Published As

Publication number Publication date
CA2515605A1 (en) 2004-10-07
WO2004085436A3 (en) 2004-11-04
EP1615921A2 (en) 2006-01-18
AR043921A1 (es) 2005-08-17
JP2006515018A (ja) 2006-05-18
WO2004085436A2 (en) 2004-10-07
EP1615921B1 (en) 2009-03-18
ATE425976T1 (de) 2009-04-15
CN1768059A (zh) 2006-05-03
DE602004020063D1 (de) 2009-04-30
US20050130984A1 (en) 2005-06-16
US7163941B2 (en) 2007-01-16
CN100341873C (zh) 2007-10-10
CL2004000631A1 (es) 2005-02-04

Similar Documents

Publication Publication Date Title
WO2005005414A3 (en) Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MY142019A (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
NO20060113L (no) Pyrrolo(3,4-c)pyrazolderivater aktive som kinase inhibitorer
PT1687305E (pt) Derivados de 1h-imidazoquinolina como inibidores de proteína quinase
MY143206A (en) 1h-thieno 2,3-c pyrazole derivatives useful as kinase i inhibitors
WO2007040438A3 (en) Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
HK1136292A1 (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MX2009006401A (es) Derivados de indazol como inhibidores de cinasa para el tratamiento del cancer.
TW200621762A (en) Novel compounds
WO2009071480A3 (en) Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
NO20063768L (no) 1H-tieno[2,3c] pyrazolderivater anvendelige som kinaseinhibitorer
TW200745136A (en) 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
WO2005014572A8 (en) Pyrimidylpyrrole derivatives active as kinase inhibitors
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
UA102219C2 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применения как ингибиторов киназы
TW200502236A (en) Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents